Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable
Healthcare AI

Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable

Matthias BastianThe Decoder
AI Summary

Anthropic is launching a drug discovery program focused on neglected diseases that major pharmaceutical companies avoid due to profitability concerns. Industry experts, including Novartis CEO, believe AI could significantly accelerate drug development from 12 years to 7-8 years while doubling success rates.

This article was originally published on The Decoder. Read the full story at the source.

Read Full Article at The Decoder

Related Articles

Google’s SensorFM turns messy wearable sensor data into a general-purpose health intelligence layer

Google’s SensorFM turns messy wearable sensor data into a general-purpose health intelligence layer

The Decoder
Meet NeuroVFM: A New Neuroimaging Foundation Model Trained With Vol-JEPA on Uncurated Clinical MRI and CT Volumes

Meet NeuroVFM: A New Neuroimaging Foundation Model Trained With Vol-JEPA on Uncurated Clinical MRI and CT Volumes

MarkTechPost
Scientists’ Side Hustle? Using AI and Quantum Computing to Generate New Peptides

Scientists’ Side Hustle? Using AI and Quantum Computing to Generate New Peptides

Wired AI
Google Research Introduces SensorFM: A Wearable Health Foundation Model Pretrained on One Trillion Minutes of Sensor Data

Google Research Introduces SensorFM: A Wearable Health Foundation Model Pretrained on One Trillion Minutes of Sensor Data

MarkTechPost